Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Karen Orostica"'
Autor:
Esperanza Bayyad, Anita Plaza, Jaime Klenner, Patricio Downey, Paulina Salas, Daniela Maragaño, Patricio Herrera, Paula Lehmann, Lily Quiroz, María Jesus Zavala, Karen Orostica, Claudio Flores, Leopoldo Ardiles, Jorge Maturana, Paola Krall
Publikováno v:
Translational Medicine Communications, Vol 8, Iss 1, Pp 1-13 (2023)
Abstract Background Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited condition associated primarily with PKD1 and PKD2 genes. However, ADPKD patients in Latin America have had limited access to comprehensive care. The ProPKD
Externí odkaz:
https://doaj.org/article/17a40060c79e4c14b179ada0b534e55d
Autor:
Javiera Garrido, Yanara Bernal, Evelin González, Alejandro Blanco, Gonzalo Sepúlveda-Hermosilla, Matías Freire, Karen Oróstica, Solange Rivas, Katherine Marcelain, Gareth Owen, Carolina Ibañez, Alejandro Corvalan, Marcelo Garrido, Rodrigo Assar, Rodrigo Lizana, Javier Cáceres-Molina, Diego Ampuero, Liliana Ramos, Paola Pérez, Osvaldo Aren, Sara Chernilo, Cristina Fernández, María Loreto Spencer, Jacqueline Flores Aguila, Giuliano Bernal Dossetto, Mónica Ahumada Olea, Germán Rasse, Carolina Sánchez, Maria Galli de Amorim, Thais F. Bartelli, Diana Noronha Nunes, Emmanuel Dias-Neto, Helano C. Freitas, Ricardo Armisén
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Tobacco use is one of the main risk factors for Lung Cancer (LC) development. However, about 10–20% of those diagnosed with the disease are never-smokers. For Non-Small Cell Lung Cancer (NSCLC) there are clear differences in bot
Externí odkaz:
https://doaj.org/article/299f116c68364c9a8cb95e5dde0ba0e8
Autor:
Yanara A. Bernal, Alejandro Blanco, Eduardo A. Sagredo, Karen Oróstica, Ivan Alfaro, Katherine Marcelain, Ricardo Armisén
Publikováno v:
Biomedicines, Vol 12, Iss 4, p 728 (2024)
Dysregulated A>I(G) RNA editing, which is mainly catalyzed by ADAR1 and is a type of post-transcriptional modification, has been linked to cancer. A low response to therapy in breast cancer (BC) is a significant contributor to mortality. However, it
Externí odkaz:
https://doaj.org/article/cc72029d95214edc80ecefec576c3c16